-6 PHARMACEUTICAL COMPOSITION CONTAINING GHRP-6 CAPABLE OF PREVENTING AND ELIMINATING FIBROSIS AND OTHER FORMS OF PATHOLOGICAL DEPOTS IN TISSUES

摘要

The present invention relates to a method for preventing and eliminating the deposition of pathologic fibrosis material in the systemic forms of internal fibrotic diseases of the liver, lung, esophagus, small intestine, kidney, blood vessels and joints, And to the use of the separation facilitating peptide of the pharmaceutical composition. In addition, the peptides interfere with and eliminate the deposition of amyloid and vitreous material in all chemical forms or tissue manifestations, including brain, cerebellum, blood vessels, liver, gastrointestinal tract, kidney, spleen, pancreas, joints and skin. In this way, it corrects for dysfunctions in cells, tissues and organs affected by such abnormal precipitation. Infiltrated or locally administered, the peptides of the present invention contribute to the prevention and elimination of keloid and hypertrophic scarring of the skin as a result of burns or other skin trauma.;Fibrosis, GHRP-6, amyloid, secretion promoting peptide